PharmaBoardroom

Yang Yoon-Sun, President and CEO – Jay Lee, Senior Director…

The founder of MEDIPOST, the producer of the only approved allogenic stem cell product in the world, disucsses their development goals for the coming…

Auh June-Sun – Chairman, Ahngook Pharm, South Korea

Auh June-Sun, chairman of Ahngook Pharm, describes the company’s increased focus on R&D and doing US FDA clinical trials. Can you describe your…

Habib Bennaceur – Country Manager, AstraZeneca, Algeria

The country manager of a British biopharmaceutical company sheds light on Algeria's potential for conducting clinical trials and offers his views on…

Mohamed Benali Khoudja – Head strategy Development North…

The general manager of a leading British research-based pharmaceutical company discusses Algeria's suitability as a destination for pre-clinical and…

Arianne Clinical Research Algeria – Cellia Habita, President…

The global CEO of Arianne, who herself happens to be American-Algerian, outlines why, in an era of clinical research globalisation, the country has…

LSK Global PS – Young-Jack Lee, CEO – South Korea

LSK Global PS CEO Young-Jack Lee discusses the influence of global CROs on the quality of Korean research, and outlines his own strategy for competing…

Sanofi Korea – Kay Bae, General Manager

Sanofi’s Korean affiliate is the fifth largest recipient of clinical trial investments after the United States, France, Germany and the United…

Korea Institute of Toxicology – Lee Sang-Joon, President

The Korean Institute of Toxicology (KIT) is a government-funded research institute that evaluates the safety of medicine, bio-related products and…

Astellas Korea – Jeong Hai-Do, President

The president of Astellas Korea offers his perspectives on Korea as a base for primary and clinical research, and the company's recent partnerships in…